Close Menu

NEW YORK (GenomeWeb) – Natera reported after the close of the market on Tuesday that its second quarter 2017 revenues were up 3 percent.

The San Carlos, California-based molecular diagnostics company reported total Q2 2017 revenues of $53.6 million compared to $52.0 million in Q2 2016, beating analysts' average estimate of $50.6 million. Total revenues included $52.3 million in product revenue and $1.3 million in licensing and other revenue.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

IBM security researchers warn of a phishing campaign targeted at organizations involved in the distribution of SARS-CoV-2 vaccines, the Verge reports.

The Illinois police have cut the number of DNA tests waiting to be run in about half, CBS Chicago reports.

A researcher accused of smuggling research materials out of the US has pleaded guilty to making false statements, according to the Associated Press.

In Science this week: gene expression signature linked to nonalcoholic fatty liver disease progression, and more.

Dec
10
Sponsored by
Tecan

CRISPR has developed into a core tool to facilitate genome editing, inspiring transformative ideas in engineering biology. 

Dec
10
Sponsored by
Illumina

Numerous companies now offer non-invasive prenatal screening (testing), many on different technology platforms.